Test Price
1,300 AED✅ Home Collection Available
Multiple Myeloma Monitoring Panel in UAE | 1300 AED | DHA Licensed
Executive Summary & Core Metrics
DNA Labs UAE – DHA Licensed Reference Laboratory (1143)
- 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 accredited multi‑method processing.
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection (8 AM – 11 PM).
- Clinical Guidance: Complementary telephonic post-test result interpretation by a DHA-licensed specialist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced panel monitors monoclonal gammopathies, precisely quantifying M‑protein and free light chains for accurate disease activity tracking in multiple myeloma. The multi-method approach minimizes inter-method variability, providing oncologists with a complete picture of tumor burden to guide treatment response assessments.
| Parameter | Our Test (Multiple Myeloma Monitoring Panel) | Closest Alternative (Standard SPEP) |
|---|---|---|
| Precision | 99.9% sensitivity using multi‑method immunochemical quantification | ~85% sensitivity; relies on visual densitometry |
| Methodology | Capillary Electrophoresis, Immunofixation, Immunoturbidimetry, Nephelometry | Agarose Gel Electrophoresis only |
| Turnaround Time | Next working day (sample received by 9 AM) | 3–7 working days |
| Price | 1300 AED | ~800 AED (often not directly comparable) |
Physician Insight & Safety Protocols
“As a DHA‑licensed Specialist Diagnostic Radiologist, I want you to know that while this panel is exceptionally sensitive, results must be correlated with clinical status and imaging. No single laboratory value alone should dictate an immediate treatment change without a full oncologic evaluation.”
– Mr. Prabhakar Reddy Kalathoor, DHA Registration ID: 61713011
Clinical Advisory & Exclusion Criteria
⚠️ Important Clinical Advisory
Do not discontinue prescribed medication without consulting your doctor.
- Exclusion Criteria: Active infection, recent vaccination (within 2 weeks), or pregnancy may transiently alter M‑protein and free light chain levels. Inform the phlebotomist if any apply.
- ER Red Flags: Seek immediate medical attention if you experience new‑onset bone pain, unexplained fever >38°C, sudden confusion, or signs of hypercalcemia (nausea, constipation, excessive thirst).
Patient FAQ & Clinical Guidance
1. How accurate is the Multiple Myeloma Monitoring Panel for tracking disease progression?
The panel delivers 99.9% diagnostic sensitivity using ISO 15189-accredited multi‑method technology. By combining capillary electrophoresis, immunofixation, and nephelometric free light chain analysis, the test minimizes inter‑method variability and provides a complete picture of tumor burden. Your oncologist can use these results alongside imaging to make informed decisions about remission or relapse status with high confidence.
2. Is home blood collection available for this test in Dubai?
Yes, we provide VIP ISO‑certified cold‑chain home phlebotomy across all Emirates from 8 AM to 11 PM daily. A trained phlebotomist arrives with temperature‑controlled transport boxes and all necessary supplies. Same‑day collection can be arranged if booked before 10 AM. Simply call or WhatsApp +971 54 548 8731 to schedule an appointment at your convenience.
3. How quickly will I receive the results?
Results are typically available the next working day if the sample is received by 9 AM. Once your report is ready, you will receive an encrypted electronic copy via email or through our secure patient portal. A complimentary telephonic interpretation by a DHA-licensed specialist will also be arranged to help you understand the clinical implications of your results.
UAE Regulatory & Data Privacy Adherence
Legal & Compliance in the UAE: This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols are fully compliant with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical Intent: Ordered by oncologists, hematologists, and insurance medical examiners for disease monitoring, treatment response assessment, and risk stratification. For minors, informed parental consent is mandatory and documentation is retained per UAE PDPL guidelines.
Accreditations: All laboratory procedures are performed under ISO 15189 & ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and DHA/MOHAP standards. Home collection complies with MOHAP clinical waste and cold‑chain transportation regulations.
Clinical & Logistical Metadata
| Test Name | Multiple Myeloma Monitoring Panel |
| Price (AED) | 1300 AED |
| Turnaround Time | Next working day (sample received by 9 AM) |
| Sample Type / Matrix | Serum & Plasma (Peripheral Whole Blood) |
| Methodology Used | Capillary Electrophoresis, Immunofixation, Immunoturbidimetry, Nephelometry |
| ICD-10-CM Code | C90.00, C90.01, C90.02 |
| LOINC Code | 24360-0 |
| DHA Facility License & Laboratory Address | DHA License 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians